Breeze Holdings Acquisition Corp.: Nasdaq/NYSE listing notice — Breeze Holdings warrants and rights to transfer from OTCQX to OTCQB after cure period lapse

Breeze Holdings Acquisition Corp.

Warrants (BRZHW) and rights (BRZHR) no longer meet OTCQX continued listing requirements; cure period expired without resolution.
Warrants and rights expected to begin trading on OTCQB on June 16, 2025; common stock (BRZH) remains on OTCQX.
Company continues pursuit of business combination with YD Biopharma Limited; transfer to OTCQB not expected to affect timing.

item 3.01 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Breeze Holdings Acquisition Corp. received a otc deficiency notice notice regarding other.

Exchange: otc
Notice: deficiency notice

Exact text from the filing

March 17, 2025, Breeze Holdings Acquisition Corp. (the “Company”) was notified by OTC Markets Group Inc. that, as of such date, its publicly traded warrants (BRZHW) and publicly traded rights (BRZHR) no longer satisfy the continued qualification requirements for the OTCQX Market, as set forth in Section 2 of the Requirements for Continued Qualification of the OTCQX Rules for U.S. Companies, which requires compliance with Section 1.1(A) of the OTCQX Eligibility Criteria, requiring the Company to have (1) net tangible assets of $2,000,000, if the Company has been in continuous operation for at l

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-25-054173

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.